UTMD — Stock Film
STOCK FILMSCENE 1/11UTMD · $69.30
Stock Expert AI presents
UTMD
Utah Medical Products, Inc
~4 min film100% real numbers0 jargon
WHAT DOES THIS COMPANY DO?
Utah Medical Products, Inc. A quick introduction.

On the stock market since 1999, it operates in the world of health and science. It has 155 employees. Now — the numbers.

on the stock market since 1999
155 employees
$220.7M market value
Revenue last year:
$0
The net profit left over:
$0
Out of every $100 in sales, $29 stays as net profit.
THE SLICE THAT TURNS INTO PROFIT: 29%

This is an established company with proven profits.

THE SALES TREND
Sales have been shrinking.

An average decline of 6% a year over the last 4 years — the most striking risk in this picture.

$49.1M
2021
$52.3M
2022
$50.2M
2023
$40.9M
2024
$38.5M
2025
Cash on hand:
$0
Total debt:
$0
The cash outweighs the debt.

If every debt were paid off today, $85.5M would still be left in the vault — a solid cushion for hard times.

INSIDE THE REPORT CARD

We compared this company with its own sector across five subjects.

A score of 50 means class average.

BUSINESS QUALITY
88
very strong

Profit power and business quality lead the class.

FINANCIAL STRENGTH
100
very strong

Debt is low and cash is strong; the finances stand solid.

VALUATION
81
very strong

The price looks reasonable next to what the company earns.

GROWTH
33
very weak

Clearly below the class average.

PRICE MOMENTUM
67
strong

Clearly above the class average — a step short of the very top.

WORTH WATCHING

Growth: Sales growth trails the sector average.

THE COUNCIL REVIEW
9

angles, checked one by one.

The 4 that stand out are on screen; the rest came back neutral.

The council scores out of 10; report-card grades are out of 100.

STRENGTHS
Fat profit per sale, but shrinking8/10
Few are betting against it10/10
WEAK SPOTS
Growth has stalled2/10
Little set aside for the future2/10
WORTH WATCHING

Revenue Growth: Sales are growing slowly.

THE FIVE-YEAR JOURNEY
Below the peak, but no collapse.

The stock trades 44% below its peak. The market has trimmed its expectations for the company.

1
THE BRIGHT SIDE · 1/3
A fat but narrowing margin

The net profit margin is 29% — still a thick cushion, though costs have been eating into it lately.

2
THE BRIGHT SIDE · 2/3
Strong cash, light debt

There is $85.8M in the vault; even if every debt were paid off, $85.5M would remain.

3
THE BRIGHT SIDE · 3/3
Pays a steady dividend

It pays out $1.24 per share each year — regular cash for whoever holds the stock.

1
THE RISKS · 1/3
Sales are shrinking

Over the last 3 years, sales fell about 10% a year on average. Profit is holding up, but a shrinking business is a risk worth watching.

2
THE RISKS · 2/3
Growth trails the sector

The growth engine is running at low revs right now. Report-card grade: 33/100.

3
THE RISKS · 3/3
Growth has stalled

The sales tempo runs behind the sector. Council score: 2/10.

FINALE · THE GRADE
A
0 / 100 · MoonshotScore

On our five-subject report card, UTMD sits near the top of the class. A high grade doesn’t mean “guaranteed win” — it means “the evidence looks strong for now.”

The takeaway: UTMD is an established business that has proven its profits for years. The real debate here isn’t the price — it’s whether the company can keep up this pace.

The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.

What would you like to do next?
Open the stock page →
This was a film — not investment advice.
Data: FMP & company filings
Jul 21, 2026 · stockexpertai.com · Stock Film